期刊文献+

奥沙利铂杂质研究进展 被引量:1

Progress on the impurities in Oxaliplatin
下载PDF
导出
摘要 以近年来国内外研究文献为基础,对奥沙利铂及其制剂杂质来源、杂质控制、制剂的稳定性等进行综述。奥沙利铂及其制剂的主要杂质为草酸、杂质B、C、D以及杂质E。杂质由合成工艺带入,同时原料及制剂在放置过程中均可降解产生上述杂质。为确保临床用药的安全有效,奥沙利铂及其制剂的杂质需要分别进行控制。 The research progress on the preparation and impurities of Oxaliplatin were summarized based on the recent documents, which generalize the impurity organization, impurity controlling and preparation stability. The principal impurities in Oxaliplatin were oxalic acid, impurity B, impurity C, impurity D and impurity E. All of the impurities were produced during the syntheses and also could be degraded from Oxaliplatin and its preparation. The impurities in Oxaliplatin and its preparation must be controlled respectively to ensure the security and effect of the drugs.
出处 《药学实践杂志》 CAS 2012年第6期412-414,436,共4页 Journal of Pharmaceutical Practice
基金 国家重大科技专项重大新药创制--输液生产线关键工艺在线监控技术平台建设课题(2009ZX09313-023)
关键词 奥沙利铂 杂质 有关物质 抗癌药物 Oxaliplatin impurity relative substance anti-cancer drug
  • 相关文献

参考文献25

  • 1Erndest W, Christen MG. Current status of platinum-based anti- tumor Drugs[J]. Chem Rev, 1999, 99: 2451.
  • 2Yoshinori K, Kenji I. Cis-platinum( Ⅱ ) complex of trans-L-I ,2- diaminocyclo-hexane[ P]. USA. 4169846. 1979-08-02.
  • 3Koji O, Yuko H, Chihiro N. Platinum compound and process of preparing same[ P]. USA. US5290961. 1994-03-01.
  • 4Frantiske Z, Anna CP. Oxaliplatin with a low content of accom- panying impurities and a method for preparetion thereof [ P ]. USA. 7351846B2. 2008-04-01.
  • 5Kidani Y. Oxaliplatin[J]. Drugs of the Future, 1989, 14 (6) : 529.
  • 6何健,刘伟平,李永年,等.抗癌药奥沙利铂的一种新合成工艺[P].中国专利.CNl837223A.2006439-27.
  • 7黄毅岚,张丹.HPLC法测定奥沙利铂中有关物质的含量[J].中国药房,2008,19(1):50-51. 被引量:10
  • 8傅萍,兰婉玲,张蕾.关于注射用奥沙利铂有关物质检查方法的探讨[J].药物分析杂志,2009,29(11):1850-1853. 被引量:5
  • 9马艺,王鑫,王娟.草酸铂周围神经毒性机制研究进展[J].国外医学(肿瘤学分册),2005,32(3):234-237. 被引量:19
  • 10Lara MP, Mario RD, Elena R, et al. Oxaliplatin-related neurotoxici- ty: How and Why? [J]. Oncology Hematology, 2006,59: 159.

二级参考文献25

  • 1张文,许立功.晚期结直肠癌的化疗进展[J].中国癌症杂志,2004,14(4):378-382. 被引量:25
  • 2马艺,王鑫,王娟.草酸铂周围神经毒性机制研究进展[J].国外医学(肿瘤学分册),2005,32(3):234-237. 被引量:19
  • 3石庆平,王铁华,张浩,丁峰,郭辉.反相高效液相色谱法检查复方维生素注射液中的有关物质[J].中国药房,2007,18(4):295-297. 被引量:3
  • 4EP. 6.0.2574.
  • 5BP. 2005. 1476.
  • 6Cassidy J, Misset JL. Oxaliplatin- related side effects: characteristics and management. Semin Oncol, 2002, 29(5 Suppl 15): 11-20.
  • 7Cavaletti G, Tredici G, Petruccioli MG, et al. Effects of different schedules of oxaliplatin treatment on the peripheral nervous system of the rat. Eur J Cancer, 2001,37(18): 2457-2463.
  • 8Cats A. New developments in systemic chemotherapy in advanced colorectal cancer. Scand J Gastroenterol Suppl, 2003,38 (239): 78-86.
  • 9Adelsberger H, Quasthoff S, Grosskreutz J, et al. The chemotherapeutic oxaliplatin alters voltage-gated Na(+) channel kinetics on rat sensory neurons. Eur J Pharmacol, 2000, 406(1): 25-32.
  • 10McKeage MJ, Hsu T, Screnci D, et al. Nucleolar damage correlates with neurotoxicity induced by different platinum drugs. Br J Cancer,2001, 85(8): 1219-1225.

共引文献36

同被引文献12

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部